
Stryker shares plunge 10% after sales guidance cut, new CEO faces tough 2027 start.
Stryker's shares dropped 10% following a guidance cut that impacted sales more than earnings, with adjusted EPS slightly below expectations and revenue missing estimates. Challenges include slow growth in hips and knees markets, supply disruptions, a...




